Policy

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

It remains unclear how Trump's executive order on workforce reductions will impact federal health agencies.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Congress could rectify the situation in upcoming spending bill or with pending legislation.

Yale researchers revealed $2.6 trillion in payouts over two decades, raising concerns about affordability and reinvestment.

Legislators question Health and Human Services leaders about potential for wrongful disclosure of private health information.

New York’s licensure rules can complicate cross-state medical practice with potential widespread professional repercussions.

Gallup, Emory University post findings about highest priorities for government leaders right now.

Several leading physician groups issued a statement condemning the removal of data from federal government websites and databases in compliance with recent executive orders.

Agency logs national data for transition month between Biden and Trump administrations.

Expenses continued to rise throughout the year, but they did not outpace inflation

WSJ: Department of Government Efficiency examines payment and contracting systems.

Comments on 2026 rule include suggestions on behavioral health, AI and more.

AdvaMed points to supply chain risks if tariffs are applied to medical devices

Kennedy’s controversial nomination advances to a full Senate vote after a 14-13 party-line decision.

Meeting includes statements for and against Kennedy, known for vaccine skepticism.

An analysis by Gibbins Advisors.

Steward Health Care tops list as biggest hospital sector bankruptcy in decades, analyst says.

Study examined Amazon’s RxPass to see how it affected medication adherence and cost

Amid mounting evidence of GLP-1 receptor agonists’ efficacy as weight loss drugs, ACP calls on policymakers to ensure access for patients in need.

Health care organizations react to president’s declaration on imported medicines and medical equipment.

A slideshow with statements of support.

Legislation could counter total 6.43% budget cut, but time is ticking away, doctors say.

Sen. Cassidy, a physician and HELP Committee chairman, was "struggling" with RFK Jr.’s nomination at the conclusion of Thursday’s confirmation hearing.

The Senate Health, Education, Labor and Pensions Committee pressed Kennedy on past comments regarding vaccine safety, Medicare knowledge and drug pricing as confirmation vote looms.

Administration, advocates could find common ground with opportunities to improve health care for physicians and patients.

Robert F. Kennedy Jr., the nominee for HHS secretary, clashed with senators over his views on vaccines, abortion access and health care finances in his first confirmation hearing.